Zenith Advisory News Today

November 1, 2023 News Release BioPorto Announces Two Poster Presentations at ASN Kidney Week 2023 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, November 1, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today that, that it will present two poster presentations at the upcoming American Society of Nephrology (ASN) Kidney Week 2023. Both poster presenta

  November 1, 2023 News Release BioPorto Announces Two Poster Presentations at ASN Kidney Week 2023 Conference COPENHAGEN,...

October 31, 2023Announcement no. 17 BioPorto provides interim Q3 results and revised 2023 Financial Guidance. COPENHAGEN, Denmark and BOSTON, MA, USA, October 31, 2023, -- BioPorto A/S today...

September 22, 2023Announcement no. 16 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, September 22, 2023, – The Board of Directors of BioPorto A/S has resolved, in accordance with...

September 19, 2023Announcement no. 15 BioPorto Initiates Search for new CFO as Neil Goldman Resigns COPENHAGEN, DENMARK and BOSTON, MA, USA, September 19, 2023, – BioPorto A/S announced...

August 1, 2023Announcement no. 14 BioPorto Announces Interim Results for the First Six Months of 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, August 1, 2023, -- BioPorto A/S today announced...

July 7, 2023News Release BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call COPENHAGEN, Denmark and BOSTON, MA, USA, July 7,...

June 29, 2023News release BioPorto Announces Submission of Response to FDA Additional Information Letter COPENHAGEN, DENMARK and BOSTON, MA, June 29,...

June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in company announcement no. 12, BioPorto A/S has...

June 9, 2023News release BioPorto A/S to Webcast with HCA and Nordnet regarding the...